Health-related quality of life in the randomized phase 3 study of ramucirumab plus docetaxel versus placebo plus docetaxel in platinum-refractory advanced urothelial carcinoma (RANGE)
2020-01-01 Necchi, A.; Nishiyama, H.; Matsubara, N.; Lee, J. -L.; Petrylak, D. P.; de Wit, R.; Drakaki, A.; Liepa, A. M.; Mao, H.; Bell-McGuinn, K.; Powles, T.
Reliability of Serum Tumor Marker Measurement to Diagnose Recurrence in Patients with Clinical Stage I Nonseminomatous Germ Cell Tumors Undergoing Active Surveillance: A Systematic Review
2021-01-01 Chakiryan, N. H.; Dahmen, A.; Cucchiara, V.; Briganti, A.; Montorsi, F.; Salonia, A.; Spiess, P. E.; Necchi, A.
Predicting outcomes in men with metastatic nonseminomatous germ cell tumors (NSGCT): Results from the IGCCCG update consortium
2021-01-01 Gillessen, S.; Sauve, N.; Collette, L.; Daugaard, G.; de Wit, R.; Albany, C.; Tryakin, A.; Fizazi, K.; Stahl, O.; Gietema, J. A.; de Giorgi, U.; Cafferty, F. H.; Hansen, A. R.; Tandstad, T.; Huddart, R. A.; Necchi, A.; Sweeney, C. J.; Garcia-Del-Muro, X.; Heng, D. Y. C.; Lorch, A.; Chovanec, M.; Winquist, E.; Grimison, P.; Feldman, D. R.; Terbuch, A.; Hentrich, M.; Bokemeyer, C.; Negaard, H.; Fankhauser, C.; Shamash, J.; Vaughn, D. J.; Sternberg, C. N.; Heidenreich, A.; Beyer, J.
Renal function outcomes in patients with muscle-invasive bladder cancer treated with neoadjuvant pembrolizumab and radical cystectomy in the PURE-01 study
2021-01-01 Trevisani, F.; Di Marco, F.; Raggi, D.; Bettiga, A.; Vago, R.; Larcher, A.; Cinque, A.; Salonia, A.; Briganti, A.; Capitanio, U.; Necchi, A.; Montorsi, F.
Optimal pathological response after neoadjuvant chemotherapy for muscle-invasive bladder cancer: results from a global, multicentre collaboration
2021-01-01 Ravi, P.; Pond, G. R.; Diamantopoulos, L. N.; Su, C.; Alva, A.; Jain, R. K.; Skelton, W. P.; Gupta, S.; Tward, J. D.; Olson, K. M.; Singh, P.; Grunewald, C. M.; Niegisch, G.; Lee, J. -L.; Gallina, A.; Bandini, M.; Necchi, A.; Mossanen, M.; Mcgregor, B. A.; Curran, C.; Grivas, P.; Sonpavde, G. P.
The obesity paradox in metastatic castration-resistant prostate cancer
2022-01-01 Martini, A.; Shah, Q. N.; Waingankar, N.; Sfakianos, J. P.; Tsao, C. -K.; Necchi, A.; Montorsi, F.; Gallagher, E. J.; Galsky, M. D.
Perioperative pembrolizumab therapy in muscle-invasive bladder cancer: Phase III KEYNOTE-866 and KEYNOTE-905/EV-303
2021-01-01 Galsky, M. D.; Hoimes, C. J.; Necchi, A.; Shore, N.; Witjes, J. A.; Steinberg, G.; Bedke, J.; Nishiyama, H.; Fang, X.; Kataria, R.; Sbar, E.; Jia, X.; Siefker-Radtke, A.
Efficacy and safety of rucaparib in previously treated, locally advanced or metastatic urothelial carcinoma from a phase 2, open-label trial (ATLAS)
2021-01-01 Grivas, P.; Loriot, Y.; Morales-Barrera, R.; Teo, M. Y.; Zakharia, Y.; Feyerabend, S.; Vogelzang, N. J.; Grande, E.; Adra, N.; Alva, A.; Necchi, A.; Rodriguez-Vida, A.; Gupta, S.; Josephs, D. H.; Srinivas, S.; Wride, K.; Thomas, D.; Simmons, A.; Loehr, A.; Dusek, R. L.; Nepert, D.; Chowdhury, S.
A feasibility study of preoperative pembrolizumab before radical nephroureterectomy in patients with high-risk, upper tract urothelial carcinoma: PURE-02
2022-01-01 Necchi, A.; Martini, A.; Raggi, D.; Cucchiara, V.; Colecchia, M.; Luciano, R.; Villa, L.; Mazzone, E.; Basile, G.; Scuderi, S.; Pederzoli, F.; Bandini, M.; Barletta, F.; Larcher, A.; Capitanio, U.; Salonia, A.; Briganti, A.; Ross, J. S.; Messina, A.; Montorsi, F.
Comprehensive genomic profiling of histologic subtypes of urethral carcinomas
2021-01-01 Jacob, J.; Necchi, A.; Grivas, P.; Hughes, M.; Sanford, T.; Mollapour, M.; Shapiro, O.; Talal, A.; Sokol, E.; Vergilio, J. -A.; Killian, J.; Lin, D.; Williams, E.; Tse, J.; Ramkissoon, S.; Severson, E.; Hemmerich, A.; Ferguson, N.; Edgerly, C.; Duncan, D.; Huang, R.; Chung, J.; Madison, R.; Alexander, B.; Venstrom, J.; Reddy, P.; Mcgregor, K.; Elvin, J.; Schrock, A.; Danziger, N.; Pavlick, D.; Ross, J.; Bratslavsky, G.
Molecular subtyping and immune-gene signatures identify a subset of early bladder tumors as candidates for single-agent immune-checkpoint inhibition
2021-01-01 Necchi, A.; Raggi, D.; Gallina, A.; Bandini, M.; de Jong, J. J.; Marandino, L.; Briganti, A.; Montorsi, F.; Davicioni, E.; Lotan, Y.; Gibb, E. A.
Molecular Characterization of Residual Bladder Cancer after Neoadjuvant Pembrolizumab
2021-01-01 Necchi, A.; de Jong, J. J.; Raggi, D.; Briganti, A.; Marandino, L.; Gallina, A.; Bandini, M.; Dabbas, B.; Davicioni, E.; Capitanio, U.; Montorsi, F.; Seiler, R.; Wright, J. L.; Lotan, Y.; Black, P. C.; Gibb, E. A.
Efficacy of Platinum Rechallenge in Metastatic Urothelial Carcinoma After Previous Platinum-Based Chemotherapy for Metastatic Disease
2021-01-01 Wong, R. L.; Ferris, L. A.; Do, O. A.; Holt, S. K.; Ramos, J. D.; Crabb, S. J.; Sternberg, C. N.; Bellmunt, J.; Ladoire, S.; De Giorgi, U.; Harshman, L. C.; Vaishampayan, U. N.; Necchi, A.; Srinivas, S.; Pal, S. K.; Niegisch, G.; Dorff, T. B.; Galsky, M. D.; Yu, E. Y.
Incidence, Patterns, and Outcomes with Adjuvant Chemotherapy for Residual Disease After Neoadjuvant Chemotherapy in Muscle-invasive Urinary Tract Cancers
2020-01-01 Martinez Chanza, N.; Werner, L.; Plimack, E.; Yu, E. Y.; Alva, A. S.; Crabb, S. J.; Powles, T.; Rosenberg, J. E.; Baniel, J.; Vaishampayan, U. N.; Berthold, D. R.; Ladoire, S.; Hussain, S. A.; Milowsky, M. I.; Agarwal, N.; Necchi, A.; Pal, S. K.; Sternberg, C. N.; Bellmunt, J.; Galsky, M. D.; Harshman, L. C.
Enfortumab vedotin after PD-1 or PD-L1 inhibitors in cisplatin-ineligible patients with advanced urothelial carcinoma (EV‑201): a multicentre, single-arm, phase 2 trial
2021-01-01 Yu, E. Y.; Petrylak, D. P.; O'Donnell, P. H.; Lee, J. -L.; van der Heijden, M. S.; Loriot, Y.; Stein, M. N.; Necchi, A.; Kojima, T.; Harrison, M. R.; Hoon Park, S.; Quinn, D. I.; Heath, E. I.; Rosenberg, J. E.; Steinberg, J.; Liang, S. -Y.; Trowbridge, J.; Campbell, M.; Mcgregor, B.; Balar, A. V.
Accuracy of Transurethral Resection of the Bladder in Detecting Variant Histology of Bladder Cancer Compared with Radical Cystectomy
2022-01-01 Lonati, C.; Baumeister, P.; Ornaghi, P. I.; Di Trapani, E.; De Cobelli, O.; Rink, M.; Karnes, R. J.; Poyet, C.; Simone, G.; Afferi, L.; Necchi, A.; Briganti, A.; Montorsi, F.; Krajewski, W.; Antonelli, A.; Cerruto, M. A.; Zamboni, S.; Simeone, C.; Mordasini, L.; Mattei, A.; Moschini, M.
The interferon landscape along the respiratory tract impacts the severity of COVID-19
2021-01-01 Sposito, Benedetta; Broggi, Achille; Pandolfi, Laura; Crotta, Stefania; Clementi, Nicola; Ferrarese, Roberto; Sisti, Sofia; Criscuolo, Elena; Spreafico, Roberto; Long, Jaclyn M.; Ambrosi, Alessandro; Liu, Enju; Frangipane, Vanessa; Saracino, Laura; Bozzini, Sara; Marongiu, Laura; Facchini, Fabio A.; Bottazzi, Andrea; Fossali, Tommaso; Colombo, Riccardo; Clementi, Massimo; Tagliabue, Elena; Chou, Janet; Pontiroli, Antonio E.; Meloni, Federica; Wack, Andreas; Mancini, Nicasio; Zanoni, Ivan
Circulating SARS-CoV-2 variants in Italy, October 2020–March 2021
2021-01-01 Lai, Alessia; Bergna, Annalisa; Menzo, Stefano; Zehender, Gianguglielmo; Caucci, Sara; Ghisetti, Valeria; Rizzo, Francesca; Maggi, Fabrizio; Cerutti, Francesco; Giurato, Giorgio; Weisz, Alessandro; Turchi, Chiara; Bruzzone, Bianca; Ceccherini Silberstein, Francesca; Clementi, Nicola; Callegaro, Annapaola; Sagradi, Fabio; Francisci, Daniela; Venanzi Rullo, Emmanuele; Vicenti, Ilaria; Clementi, Massimo; Galli, Massimo; Balotta, Claudia; Gori, Maria; Bagnarelli, Patrizia; Baj, Andreina; Novazzi, Federica; Orsi, Andrea; Caligiuri, Patrizia; Boccotti, Simona; Bellocchi, Maria Concetta; Sarmati, Loredana; Andreoni, Massimo; Mancini, Nicasio; Criscuolo, Elena; Gallitelli, Rosa; Testa, Sophie; Dragoni, Filippo; Zazzi, Maurizio
Maturation signatures of conventional dendritic cell subtypes in COVID‐19 suggest direct viral sensing
2022-01-01 Marongiu, Laura; Protti, Giulia; Facchini, Fabio A.; Valache, Mihai; Mingozzi, Francesca; Ranzani, Valeria; Putignano, Anna Rita; Salviati, Lorenzo; Bevilacqua, Valeria; Curti, Serena; Crosti, Mariacristina; Sarnicola, Maria Lucia; D'Angiò, Mariella; Bettini, Laura Rachele; Biondi, Andrea; Nespoli, Luca; Tamini, Nicolò; Clementi, Nicola; Mancini, Nicasio; Abrignani, Sergio; Spreafico, Roberto; Granucci, Francesca
Characterization of a lineage c.36 sars-cov-2 isolate with reduced susceptibility to neutralization circulating in lombardy, italy
2021-01-01 Castelli, Matteo; Baj, Andreina; Criscuolo, Elena; Ferrarese, Roberto; Diotti, Roberta A.; Sampaolo, Michela; Novazzi, Federica; Dalla Gasperina, Daniela; Focosi, Daniele; Ferrari, Davide; Locatelli, Massimo; Clementi, Massimo; Clementi, Nicola; Maggi, Fabrizio; Mancini, Nicasio
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Health-related quality of life in the randomized phase 3 study of ramucirumab plus docetaxel versus placebo plus docetaxel in platinum-refractory advanced urothelial carcinoma (RANGE) | 1-gen-2020 | Necchi, A.; Nishiyama, H.; Matsubara, N.; Lee, J. -L.; Petrylak, D. P.; de Wit, R.; Drakaki, A.; Liepa, A. M.; Mao, H.; Bell-McGuinn, K.; Powles, T. | |
| Reliability of Serum Tumor Marker Measurement to Diagnose Recurrence in Patients with Clinical Stage I Nonseminomatous Germ Cell Tumors Undergoing Active Surveillance: A Systematic Review | 1-gen-2021 | Chakiryan, N. H.; Dahmen, A.; Cucchiara, V.; Briganti, A.; Montorsi, F.; Salonia, A.; Spiess, P. E.; Necchi, A. | |
| Predicting outcomes in men with metastatic nonseminomatous germ cell tumors (NSGCT): Results from the IGCCCG update consortium | 1-gen-2021 | Gillessen, S.; Sauve, N.; Collette, L.; Daugaard, G.; de Wit, R.; Albany, C.; Tryakin, A.; Fizazi, K.; Stahl, O.; Gietema, J. A.; de Giorgi, U.; Cafferty, F. H.; Hansen, A. R.; Tandstad, T.; Huddart, R. A.; Necchi, A.; Sweeney, C. J.; Garcia-Del-Muro, X.; Heng, D. Y. C.; Lorch, A.; Chovanec, M.; Winquist, E.; Grimison, P.; Feldman, D. R.; Terbuch, A.; Hentrich, M.; Bokemeyer, C.; Negaard, H.; Fankhauser, C.; Shamash, J.; Vaughn, D. J.; Sternberg, C. N.; Heidenreich, A.; Beyer, J. | |
| Renal function outcomes in patients with muscle-invasive bladder cancer treated with neoadjuvant pembrolizumab and radical cystectomy in the PURE-01 study | 1-gen-2021 | Trevisani, F.; Di Marco, F.; Raggi, D.; Bettiga, A.; Vago, R.; Larcher, A.; Cinque, A.; Salonia, A.; Briganti, A.; Capitanio, U.; Necchi, A.; Montorsi, F. | |
| Optimal pathological response after neoadjuvant chemotherapy for muscle-invasive bladder cancer: results from a global, multicentre collaboration | 1-gen-2021 | Ravi, P.; Pond, G. R.; Diamantopoulos, L. N.; Su, C.; Alva, A.; Jain, R. K.; Skelton, W. P.; Gupta, S.; Tward, J. D.; Olson, K. M.; Singh, P.; Grunewald, C. M.; Niegisch, G.; Lee, J. -L.; Gallina, A.; Bandini, M.; Necchi, A.; Mossanen, M.; Mcgregor, B. A.; Curran, C.; Grivas, P.; Sonpavde, G. P. | |
| The obesity paradox in metastatic castration-resistant prostate cancer | 1-gen-2022 | Martini, A.; Shah, Q. N.; Waingankar, N.; Sfakianos, J. P.; Tsao, C. -K.; Necchi, A.; Montorsi, F.; Gallagher, E. J.; Galsky, M. D. | |
| Perioperative pembrolizumab therapy in muscle-invasive bladder cancer: Phase III KEYNOTE-866 and KEYNOTE-905/EV-303 | 1-gen-2021 | Galsky, M. D.; Hoimes, C. J.; Necchi, A.; Shore, N.; Witjes, J. A.; Steinberg, G.; Bedke, J.; Nishiyama, H.; Fang, X.; Kataria, R.; Sbar, E.; Jia, X.; Siefker-Radtke, A. | |
| Efficacy and safety of rucaparib in previously treated, locally advanced or metastatic urothelial carcinoma from a phase 2, open-label trial (ATLAS) | 1-gen-2021 | Grivas, P.; Loriot, Y.; Morales-Barrera, R.; Teo, M. Y.; Zakharia, Y.; Feyerabend, S.; Vogelzang, N. J.; Grande, E.; Adra, N.; Alva, A.; Necchi, A.; Rodriguez-Vida, A.; Gupta, S.; Josephs, D. H.; Srinivas, S.; Wride, K.; Thomas, D.; Simmons, A.; Loehr, A.; Dusek, R. L.; Nepert, D.; Chowdhury, S. | |
| A feasibility study of preoperative pembrolizumab before radical nephroureterectomy in patients with high-risk, upper tract urothelial carcinoma: PURE-02 | 1-gen-2022 | Necchi, A.; Martini, A.; Raggi, D.; Cucchiara, V.; Colecchia, M.; Luciano, R.; Villa, L.; Mazzone, E.; Basile, G.; Scuderi, S.; Pederzoli, F.; Bandini, M.; Barletta, F.; Larcher, A.; Capitanio, U.; Salonia, A.; Briganti, A.; Ross, J. S.; Messina, A.; Montorsi, F. | |
| Comprehensive genomic profiling of histologic subtypes of urethral carcinomas | 1-gen-2021 | Jacob, J.; Necchi, A.; Grivas, P.; Hughes, M.; Sanford, T.; Mollapour, M.; Shapiro, O.; Talal, A.; Sokol, E.; Vergilio, J. -A.; Killian, J.; Lin, D.; Williams, E.; Tse, J.; Ramkissoon, S.; Severson, E.; Hemmerich, A.; Ferguson, N.; Edgerly, C.; Duncan, D.; Huang, R.; Chung, J.; Madison, R.; Alexander, B.; Venstrom, J.; Reddy, P.; Mcgregor, K.; Elvin, J.; Schrock, A.; Danziger, N.; Pavlick, D.; Ross, J.; Bratslavsky, G. | |
| Molecular subtyping and immune-gene signatures identify a subset of early bladder tumors as candidates for single-agent immune-checkpoint inhibition | 1-gen-2021 | Necchi, A.; Raggi, D.; Gallina, A.; Bandini, M.; de Jong, J. J.; Marandino, L.; Briganti, A.; Montorsi, F.; Davicioni, E.; Lotan, Y.; Gibb, E. A. | |
| Molecular Characterization of Residual Bladder Cancer after Neoadjuvant Pembrolizumab | 1-gen-2021 | Necchi, A.; de Jong, J. J.; Raggi, D.; Briganti, A.; Marandino, L.; Gallina, A.; Bandini, M.; Dabbas, B.; Davicioni, E.; Capitanio, U.; Montorsi, F.; Seiler, R.; Wright, J. L.; Lotan, Y.; Black, P. C.; Gibb, E. A. | |
| Efficacy of Platinum Rechallenge in Metastatic Urothelial Carcinoma After Previous Platinum-Based Chemotherapy for Metastatic Disease | 1-gen-2021 | Wong, R. L.; Ferris, L. A.; Do, O. A.; Holt, S. K.; Ramos, J. D.; Crabb, S. J.; Sternberg, C. N.; Bellmunt, J.; Ladoire, S.; De Giorgi, U.; Harshman, L. C.; Vaishampayan, U. N.; Necchi, A.; Srinivas, S.; Pal, S. K.; Niegisch, G.; Dorff, T. B.; Galsky, M. D.; Yu, E. Y. | |
| Incidence, Patterns, and Outcomes with Adjuvant Chemotherapy for Residual Disease After Neoadjuvant Chemotherapy in Muscle-invasive Urinary Tract Cancers | 1-gen-2020 | Martinez Chanza, N.; Werner, L.; Plimack, E.; Yu, E. Y.; Alva, A. S.; Crabb, S. J.; Powles, T.; Rosenberg, J. E.; Baniel, J.; Vaishampayan, U. N.; Berthold, D. R.; Ladoire, S.; Hussain, S. A.; Milowsky, M. I.; Agarwal, N.; Necchi, A.; Pal, S. K.; Sternberg, C. N.; Bellmunt, J.; Galsky, M. D.; Harshman, L. C. | |
| Enfortumab vedotin after PD-1 or PD-L1 inhibitors in cisplatin-ineligible patients with advanced urothelial carcinoma (EV‑201): a multicentre, single-arm, phase 2 trial | 1-gen-2021 | Yu, E. Y.; Petrylak, D. P.; O'Donnell, P. H.; Lee, J. -L.; van der Heijden, M. S.; Loriot, Y.; Stein, M. N.; Necchi, A.; Kojima, T.; Harrison, M. R.; Hoon Park, S.; Quinn, D. I.; Heath, E. I.; Rosenberg, J. E.; Steinberg, J.; Liang, S. -Y.; Trowbridge, J.; Campbell, M.; Mcgregor, B.; Balar, A. V. | |
| Accuracy of Transurethral Resection of the Bladder in Detecting Variant Histology of Bladder Cancer Compared with Radical Cystectomy | 1-gen-2022 | Lonati, C.; Baumeister, P.; Ornaghi, P. I.; Di Trapani, E.; De Cobelli, O.; Rink, M.; Karnes, R. J.; Poyet, C.; Simone, G.; Afferi, L.; Necchi, A.; Briganti, A.; Montorsi, F.; Krajewski, W.; Antonelli, A.; Cerruto, M. A.; Zamboni, S.; Simeone, C.; Mordasini, L.; Mattei, A.; Moschini, M. | |
| The interferon landscape along the respiratory tract impacts the severity of COVID-19 | 1-gen-2021 | Sposito, Benedetta; Broggi, Achille; Pandolfi, Laura; Crotta, Stefania; Clementi, Nicola; Ferrarese, Roberto; Sisti, Sofia; Criscuolo, Elena; Spreafico, Roberto; Long, Jaclyn M.; Ambrosi, Alessandro; Liu, Enju; Frangipane, Vanessa; Saracino, Laura; Bozzini, Sara; Marongiu, Laura; Facchini, Fabio A.; Bottazzi, Andrea; Fossali, Tommaso; Colombo, Riccardo; Clementi, Massimo; Tagliabue, Elena; Chou, Janet; Pontiroli, Antonio E.; Meloni, Federica; Wack, Andreas; Mancini, Nicasio; Zanoni, Ivan | |
| Circulating SARS-CoV-2 variants in Italy, October 2020–March 2021 | 1-gen-2021 | Lai, Alessia; Bergna, Annalisa; Menzo, Stefano; Zehender, Gianguglielmo; Caucci, Sara; Ghisetti, Valeria; Rizzo, Francesca; Maggi, Fabrizio; Cerutti, Francesco; Giurato, Giorgio; Weisz, Alessandro; Turchi, Chiara; Bruzzone, Bianca; Ceccherini Silberstein, Francesca; Clementi, Nicola; Callegaro, Annapaola; Sagradi, Fabio; Francisci, Daniela; Venanzi Rullo, Emmanuele; Vicenti, Ilaria; Clementi, Massimo; Galli, Massimo; Balotta, Claudia; Gori, Maria; Bagnarelli, Patrizia; Baj, Andreina; Novazzi, Federica; Orsi, Andrea; Caligiuri, Patrizia; Boccotti, Simona; Bellocchi, Maria Concetta; Sarmati, Loredana; Andreoni, Massimo; Mancini, Nicasio; Criscuolo, Elena; Gallitelli, Rosa; Testa, Sophie; Dragoni, Filippo; Zazzi, Maurizio | |
| Maturation signatures of conventional dendritic cell subtypes in COVID‐19 suggest direct viral sensing | 1-gen-2022 | Marongiu, Laura; Protti, Giulia; Facchini, Fabio A.; Valache, Mihai; Mingozzi, Francesca; Ranzani, Valeria; Putignano, Anna Rita; Salviati, Lorenzo; Bevilacqua, Valeria; Curti, Serena; Crosti, Mariacristina; Sarnicola, Maria Lucia; D'Angiò, Mariella; Bettini, Laura Rachele; Biondi, Andrea; Nespoli, Luca; Tamini, Nicolò; Clementi, Nicola; Mancini, Nicasio; Abrignani, Sergio; Spreafico, Roberto; Granucci, Francesca | |
| Characterization of a lineage c.36 sars-cov-2 isolate with reduced susceptibility to neutralization circulating in lombardy, italy | 1-gen-2021 | Castelli, Matteo; Baj, Andreina; Criscuolo, Elena; Ferrarese, Roberto; Diotti, Roberta A.; Sampaolo, Michela; Novazzi, Federica; Dalla Gasperina, Daniela; Focosi, Daniele; Ferrari, Davide; Locatelli, Massimo; Clementi, Massimo; Clementi, Nicola; Maggi, Fabrizio; Mancini, Nicasio |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile
Scopri
Tipologia
- 1 Contributo su Rivista39385
Data di pubblicazione
- In corso di stampa9
- 2020 - 202711472
- 2010 - 201915948
- 2000 - 20097460
- 1990 - 19993485
- 1980 - 1989933
- 1970 - 197977
- 1959 - 19591
Editore
- Elsevier Inc.802
- Elsevier B.V.767
- John Wiley and Sons Inc524
- Springer Science and Business Med...516
- Oxford University Press483
- Lippincott Williams and Wilkins420
- Springer360
- MDPI347
- Elsevier Ltd330
- Springer Nature281
Rivista
- EUROPEAN UROLOGY529
- BLOOD372
- PLOS ONE312
- JOURNAL OF NEUROLOGY283
- EUROPEAN JOURNAL OF HEART FAILURE280
- NEUROLOGY268
- DIGESTIVE AND LIVER DISEASE245
- EUROPEAN HEART JOURNAL224
- MULTIPLE SCLEROSIS216
- SCIENTIFIC REPORTS212
Keyword
- Humans3553
- Male2080
- Female1864
- Middle Aged1472
- Aged1290
- Adult1100
- COVID-19629
- Retrospective Studies628
- Treatment Outcome603
- Prognosis481
Lingua
- eng28792
- ita1958
- fre64
- und55
- spa34
- ger25
- por12
- enm6
- rus6
- grc3
Accesso al fulltext
- no fulltext33605
- open3381
- reserved2292
- partially open99
- embargoed7
- mixed1